Josep Tabernero

机构：Universitat de Vic - Universitat Central de Catalunya, Hebron University, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, CIBBIM-Nanomedicine, Vall d'Hebron Institute of Oncology · ORCID：0000-0002-2495-8139

发表论文 2699 篇 · 总被引 129466 次 · h-index 146

代表论文

• Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy (2025 · Clinical Cancer Research · 被引 4)
• Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial (2026 · Journal of Clinical Oncology · 被引 3)
• Erdafitinib in Patients with FGFR- Altered Advanced or Metastatic Cholangiocarcinoma (2025 · Clinical Cancer Research · 被引 3)
• Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients (2026 · Genes · 被引 1)
• Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)
• Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities (2025 · Molecular Oncology · 被引 1)